Di Fu

2.1k total citations · 1 hit paper
76 papers, 1.3k citations indexed

About

Di Fu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Di Fu has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Di Fu's work include Lymphoma Diagnosis and Treatment (20 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (8 papers). Di Fu is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (8 papers). Di Fu collaborates with scholars based in China, France and United States. Di Fu's co-authors include Philip K. Moore, Madhav Bhatia, Shabbir Moochhala, Li Wang, Pengpeng Xu, Shu Cheng, Weili Zhao, Hongmei Yi, Weili Zhao and Yan Zhao and has published in prestigious journals such as Cancer Cell, Scientific Reports and The FASEB Journal.

In The Last Decade

Di Fu

71 papers receiving 1.3k citations

Hit Papers

Butyrate-producing Eubacterium rectale suppresses lymphom... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Fu China 19 496 314 303 231 223 76 1.3k
Zhi Liang China 22 661 1.3× 85 0.3× 144 0.5× 332 1.4× 528 2.4× 59 1.6k
Kathryn P. Burdon Australia 37 1.5k 2.9× 304 1.0× 93 0.3× 208 0.9× 88 0.4× 156 3.9k
Andrew Gibb United States 19 957 1.9× 156 0.5× 179 0.6× 177 0.8× 46 0.2× 34 2.1k
Benjamin Heng Australia 24 561 1.1× 149 0.5× 428 1.4× 223 1.0× 24 0.1× 66 1.6k
Julia Winkler United States 22 619 1.2× 95 0.3× 188 0.6× 231 1.0× 54 0.2× 74 1.6k
Vanessa Dubois Belgium 22 1.0k 2.0× 146 0.5× 306 1.0× 93 0.4× 37 0.2× 41 2.3k
S. Michalak Poland 20 353 0.7× 289 0.9× 250 0.8× 412 1.8× 20 0.1× 149 1.7k
Olivera Marković Serbia 16 221 0.4× 135 0.4× 183 0.6× 151 0.7× 48 0.2× 90 1.1k
Shinpei Nakazawa Japan 24 611 1.2× 127 0.4× 192 0.6× 212 0.9× 36 0.2× 105 1.7k

Countries citing papers authored by Di Fu

Since Specialization
Citations

This map shows the geographic impact of Di Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Fu more than expected).

Fields of papers citing papers by Di Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Fu. The network helps show where Di Fu may publish in the future.

Co-authorship network of co-authors of Di Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Di Fu. A scholar is included among the top collaborators of Di Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Fu. Di Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuqing, Shuo Wang, Hongmei Yi, et al.. (2025). Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology. Cell Reports Medicine. 6(4). 102030–102030. 3 indexed citations
3.
Hou, Qiang, et al.. (2025). A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast. Scientific Reports. 15(1). 2204–2204. 4 indexed citations
4.
Zheng, Zhong, Rui Sun, Xiangqin Weng, et al.. (2025). Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma. Signal Transduction and Targeted Therapy. 10(1). 29–29. 3 indexed citations
6.
Li, Hui, Pengfei Wang, Wei Luo, et al.. (2024). CD36-mediated ferroptosis destabilizes CD4+ T cell homeostasis in acute Stanford type-A aortic dissection. Cell Death and Disease. 15(9). 669–669. 7 indexed citations
9.
Liu, Suling, Qian Qiu, Di Fu, et al.. (2024). Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease. Arthritis Research & Therapy. 26(1). 184–184. 6 indexed citations
10.
Fu, Di, et al.. (2023). Design of all-sky airglow imaging spectrometers in the middle and upper atmosphere. Optik. 287. 171087–171087. 3 indexed citations
11.
Shi, Qing, Yang He, Hongmei Yi, et al.. (2023). Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial. Cancer Communications. 43(8). 896–908. 4 indexed citations
13.
Fu, Di, Guanhao He, Ziqiang Lin, et al.. (2023). Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023. China CDC Weekly. 5(17). 369–373. 47 indexed citations
14.
Shen, Rong, Di Fu, Lei Dong, et al.. (2023). Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal Transduction and Targeted Therapy. 8(1). 145–145. 46 indexed citations
15.
Sheng, Lingshuang, Di Fu, Yiwen Cao, et al.. (2022). Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers. Frontiers in Oncology. 12. 790720–790720. 6 indexed citations
16.
Yan, Zi‐Xun, Jingjing Wen, Di Fu, et al.. (2021). CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis. Molecular Cancer. 20(1). 153–153. 24 indexed citations
17.
Luo, Wei, Hao Tang, Di Fu, et al.. (2021). Association of Apoptosis-Mediated CD4+ T Lymphopenia With Poor Outcome After Type A Aortic Dissection Surgery. Frontiers in Cardiovascular Medicine. 8. 747467–747467. 8 indexed citations
18.
Zheng, Zhong, Rui Sun, Di Fu, et al.. (2019). MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells. Molecular Cancer. 18(1). 54–54. 81 indexed citations
19.
Xu, Junmei, Lijian Tao, Di Fu, et al.. (2007). Activation of interleukin-1beta (IL-1β) signaling in the spinal cord in the rats with experimental cardiac injury. International Journal of Cardiology. 128(3). 413–418. 4 indexed citations
20.
Fu, Di, Qulian Guo, Yuhang Ai, et al.. (2006). Glial Activation and Segmental Upregulation of Interleukin-1β (IL-1β) in the Rat Spinal Cord after Surgical Incision. Neurochemical Research. 31(3). 333–340. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026